ADVFN ADVFN

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Caratteristiche principali

Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Amylyx Pharmaceuticals Inc

Amylyx Pharmaceuticals Inc (AMLX)

13,32
-0,99
(-6,92%)
Chiuso 07 Giugno 10:00PM
13,29
-0,03
(-0,23%)
Dopo le ore di negoziazione: 1:56AM

Amylyx Pharmaceuticals Inc (AMLX) Operazioni degli insider

-
Filtra per:
Data Nome del titolare Azioni transazionate Intervallo di valore ($) Tipo di transazione Intervallo di prezzo ($) Azioni a fine dichiarazione % di variazione
2026-05-21Ms. Karen Mindy FirestoneIndependent Director3,80k51,34kAcquisto13,5166,90k6,02%
2026-03-02Mr. James M. FratesCFO-7,91k114,85kVendita14,52210,02k-3,63%
2026-03-02Ms. Gina M. MazzarielloChief Legal Officer & General Counsel-6,84k99,38kVendita14,5259,04k-10,39%
2026-03-02Dr. Camille L. BedrosianChief Medical Officer-6,46k94,21kVendita14,5888,81k-6,78%
2026-03-02Mr. Joshua B. CohenCo-Founder, Co-CEO & Director-29,28k424,12kVendita14,483,11M-0,93%
2026-03-02Mr. Justin B. KleeCo-CEO & Director-29,28k423,76kVendita14,473,07M-0,95%
2026-02-23Ms. Gina M. MazzarielloChief Legal Officer & General Counsel-3,42k48,35kVendita14,1440,76k-7,74%
2026-02-02Mr. Justin B. KleeCo-CEO & Director-15,50k227,62kVendita14,693,10M-0,50%
2026-02-02Ms. Gina M. MazzarielloChief Legal Officer & General Counsel-3,45k50,52kVendita14,6543,09k-7,41%
2026-02-02Mr. Joshua B. CohenCo-Founder, Co-CEO & Director-15,50k227,59kVendita14,683,10M-0,50%
2026-02-02Mr. James M. FratesCFO-3,56k52,10kVendita14,65200,83k-1,74%
2026-01-15Mr. Justin B. KleeCo-CEO & Director61,81k467,92kDerivative Exercise and Retained Stock7,573,08M2,05%
2026-01-15Mr. Justin B. KleeCo-CEO & Director-138,19k831,49kDerivative Exercise and Sale7,57 - 13,893,08M-
2026-01-15Mr. Joshua B. CohenCo-Founder, Co-CEO & Director61,83k468,08kDerivative Exercise and Retained Stock7,573,08M2,05%
2026-01-15Mr. Joshua B. CohenCo-Founder, Co-CEO & Director-138,17k832,17kDerivative Exercise and Sale7,57 - 13,833,08M-
2026-01-12Dr. George Mclean MilneIndependent Chairman of the Board-17,78k0,00Other Disposition-812,88k-2,14%
2026-01-06Mr. Justin B. KleeCo-CEO & Director-7,72k85,59kVendita11,093,02M-0,26%
2026-01-06Mr. Joshua B. CohenCo-Founder, Co-CEO & Director-7,72k85,60kVendita11,093,02M-0,26%
2026-01-06Mr. James M. FratesCFO-3,33k36,95kVendita11,11194,38k-1,68%
2025-12-23Ms. Karen Mindy FirestoneIndependent Director8,10k100,85kAcquisto12,4563,10k14,73%
2025-12-01Dr. Camille L. BedrosianChief Medical Officer-6,58k94,42kVendita14,3578,17k-7,76%
2025-09-30Dr. Camille L. BedrosianChief Medical Officer-12,04k175,52kVendita14,5870,17k-14,65%
2025-09-30Ms. Gina M. MazzarielloChief Legal Officer & General Counsel-8,83k128,67kVendita14,5837,37k-19,11%
2025-09-30Mr. Joshua B. CohenCo-Founder, Co-CEO & Director-29,93k429,47kVendita14,34 - 15,003,01M-0,99%
2025-09-30Mr. James M. FratesCFO-10,56k154,65kVendita14,65189,79k-5,27%
2025-09-30Mr. Justin B. KleeCo-CEO & Director-29,98k430,95kVendita14,37 - 15,013,01M-0,99%
2025-08-12Ms. Gina M. MazzarielloChief Legal Officer & General Counsel-30,00k246,15kAutomatic Disposition8,07 - 8,3418,81k-61,46%